Can amide proton transfer–weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
- 18 March 2019
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 29 (10) , 5298-5306
Abstract
Objectives To determine the utility of the amide proton transfer–weighted MR imaging in differentiating the WHO grade and predict proliferative activity of meningioma. Methods Fifty-three patients with WHO grade I meningiomas and 26 patients with WHO grade II meningiomas underwent conventional and APT-weighted sequences on a 3.0 Tesla MR before clinical intervention. The APT-weighted (APTw) parameters in the solid tumor region were obtained and compared between two grades using the t test; the receiver operating characteristic (ROC) curve was used to assess the best parameter for predicting the grade of meningiomas. Pearson’s correlation coefficient was calculated between the APTwmax and Ki-67 labeling index in meningiomas. Results The APTwmax and APTwmean values were not significantly different between WHO grade I and grade II meningiomas (p = 0.103 and p = 0.318). The APTwmin value was higher and the APTwmax-min value was lower in WHO grade II meningiomas than in WHO grade I tumors (p = 0.027 and p = 0.019). But the APTwmin was higher and the APTwmax-min was lower in microcystic meningiomas than in WHO grade II meningiomas (p = 0.001 and p = 0.006). The APTwmin combined with APTwmax-min showed the best diagnostic performance in predicting the grade of meningiomas with an AUC of 0.772. The APTwmax value was positively correlated with Ki-67 labeling index (r = 0.817, p < 0.001) in meningiomas; the regression equation for the Ki-67 labeling index (%) (Y) and APTwmax (%) (X) was Y = 4.9 × X − 12.4 (R2 = 0.667, p < 0.001). Conclusion As a noninvasive imaging method, the ability of APTw-MR imaging in differentiating the grade of meningiomas is limited, but the technology can be used to predict the proliferative activity of meningioma. Key Points • The APTw min value was higher and the APTw max-min value was lower in WHO grade II meningioma than in grade I tumors. • The APTw min value was higher and the APTw max-min value was lower in microcystic meningiomas than in WHO grade II meningiomas. • The APTw max value was positively correlated with meningioma proliferation index.Keywords
Funding Information
- Guangdong Provincial Natural Science Foundation (2014A030313271)
- Guangdong provincial science and technology project (2014A020212726)
- Southern Medical University Clinical Research Project (LC2016ZD028)
- National Institutes of Health (R01EB009731, R01CA166171)
This publication has 37 references indexed in Scilit:
- Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRINMR in Biomedicine, 2013
- Characterization of Lung Cancer by Amide Proton Transfer (APT) Imaging: An In-Vivo Study in an Orthotopic Mouse ModelPLOS ONE, 2013
- Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edemaJournal of Neuro-Oncology, 2012
- Amide proton transfer imaging of the breast at 3 T: Establishing reproducibility and possible feasibility assessing chemotherapy responseMagnetic Resonance in Medicine, 2012
- Amide proton transfer MR imaging of prostate cancer: A preliminary studyJournal of Magnetic Resonance Imaging, 2011
- Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptidesNature Medicine, 2010
- MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrastNeuroImage, 2010
- Diffusion-weighted imaging does not predict histological grading in meningiomasActa Neurochirurgica, 2010
- Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy CohortRadiology, 2007
- Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRINature Medicine, 2003